DK1392271T3 - Slugetablet indeholdende paracetamol - Google Patents

Slugetablet indeholdende paracetamol

Info

Publication number
DK1392271T3
DK1392271T3 DK02747339T DK02747339T DK1392271T3 DK 1392271 T3 DK1392271 T3 DK 1392271T3 DK 02747339 T DK02747339 T DK 02747339T DK 02747339 T DK02747339 T DK 02747339T DK 1392271 T3 DK1392271 T3 DK 1392271T3
Authority
DK
Denmark
Prior art keywords
tablet containing
containing paracetamol
swallowing tablet
swallowing
paracetamol
Prior art date
Application number
DK02747339T
Other languages
Danish (da)
English (en)
Inventor
Timothy James Grattan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1392271T3 publication Critical patent/DK1392271T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02747339T 2001-06-08 2002-06-03 Slugetablet indeholdende paracetamol DK1392271T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0114069.8A GB0114069D0 (en) 2001-06-08 2001-06-08 Composition
PCT/EP2002/006046 WO2002100391A1 (en) 2001-06-08 2002-06-03 Swallow tablet comprising paracetamol

Publications (1)

Publication Number Publication Date
DK1392271T3 true DK1392271T3 (da) 2008-06-30

Family

ID=9916252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02747339T DK1392271T3 (da) 2001-06-08 2002-06-03 Slugetablet indeholdende paracetamol

Country Status (25)

Country Link
US (1) US7993673B2 (pt)
EP (1) EP1392271B1 (pt)
JP (1) JP2004533461A (pt)
KR (1) KR100846945B1 (pt)
CN (1) CN1538837A (pt)
AR (1) AR036085A1 (pt)
AT (1) ATE389392T1 (pt)
AU (1) AU2002317772B2 (pt)
BR (1) BR0210224A (pt)
CA (1) CA2449520C (pt)
CO (1) CO5540295A2 (pt)
CZ (1) CZ301449B6 (pt)
DE (1) DE60225686T2 (pt)
DK (1) DK1392271T3 (pt)
ES (1) ES2300452T3 (pt)
GB (1) GB0114069D0 (pt)
HK (1) HK1062896A1 (pt)
HU (1) HUP0400127A2 (pt)
MX (1) MXPA03011317A (pt)
MY (1) MY136059A (pt)
NZ (1) NZ529974A (pt)
PL (1) PL367985A1 (pt)
TW (1) TWI326212B (pt)
WO (1) WO2002100391A1 (pt)
ZA (1) ZA200309172B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20080287456A1 (en) * 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
CA2566331C (en) * 2004-05-28 2011-03-15 Imaginot Pty Ltd. Oral delivery system
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
CN100356918C (zh) * 2004-09-30 2007-12-26 吴筑华 一种治疗肠炎的鞣酸苦参总碱肠溶速释制剂
JP2009517346A (ja) * 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
GB0607085D0 (en) * 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
DE102007041588A1 (de) * 2007-09-01 2009-03-05 Lts Lohmann Therapie-Systeme Ag Arzneimittel mit Hefe
GB0813929D0 (en) 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method
EA201391643A1 (ru) * 2011-05-06 2014-07-30 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Составы с замедленным высвобождением парацетамола
WO2014203140A1 (en) * 2013-06-22 2014-12-24 Wockhardt Limited Solid oral pharmaceutical compositions comprising fixed dose combination of acetaminophen, dicyclomine and dextropropoxyphene or salts thereof
EP3345591A1 (en) * 2017-01-06 2018-07-11 Oystershell NV Oral dosage form for enhanced solubilization of a poorly soluble active agent and method of preparation
CN108451916B (zh) * 2018-06-19 2020-08-14 重庆国泰康宁制药有限责任公司 一种对乙酰氨基酚药物组合物制剂及其制备方法
CA3115122A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
CN115998698B (zh) * 2023-02-07 2024-03-15 福州海王福药制药有限公司 一种碳酸氢钠片的制备工艺

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3390049A (en) * 1964-12-23 1968-06-25 Smith Kline French Lab Pharmaceutical tablets coated with wax-free ammonia solubilized water soluble shellac
GB1583602A (en) * 1977-05-26 1981-01-28 Sterwin Ag N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
US4915953A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering acetaminophen or phenylpropanolamine
US5073377A (en) * 1988-11-03 1991-12-17 Miles Inc. Method of preparing oral dosage forms with a granulating composition
CA2021548A1 (en) 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
ES2097155T3 (es) * 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
US5750145A (en) * 1995-07-28 1998-05-12 Bristol-Myers Squibb Company Stable gelatin coated aspirin tablets
US5807580A (en) 1996-10-30 1998-09-15 Mcneil-Ppc, Inc. Film coated tablet compositions having enhanced disintegration characteristics
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
GB9704524D0 (en) 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4947833B2 (ja) * 1997-07-25 2012-06-06 アルペックス・ファルマ・ソシエテ・アノニム 速崩壊性口内溶解錠の製造に適した顆粒の製造方法
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
US6277409B1 (en) * 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
ES2174734B1 (es) 2000-11-03 2003-10-01 Belmac S A Lab Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.

Also Published As

Publication number Publication date
NZ529974A (en) 2006-02-24
EP1392271B1 (en) 2008-03-19
JP2004533461A (ja) 2004-11-04
HUP0400127A2 (hu) 2004-07-28
GB0114069D0 (en) 2001-08-01
ES2300452T3 (es) 2008-06-16
PL367985A1 (en) 2005-03-21
CA2449520C (en) 2011-12-06
AU2002317772B2 (en) 2006-04-06
ZA200309172B (en) 2004-11-25
CA2449520A1 (en) 2002-12-19
DE60225686T2 (de) 2009-04-16
ATE389392T1 (de) 2008-04-15
TWI326212B (en) 2010-06-21
CZ301449B6 (cs) 2010-03-03
WO2002100391A1 (en) 2002-12-19
DE60225686D1 (de) 2008-04-30
AR036085A1 (es) 2004-08-11
EP1392271A1 (en) 2004-03-03
MY136059A (en) 2008-08-29
US20040170681A1 (en) 2004-09-02
CO5540295A2 (es) 2005-07-29
HK1062896A1 (en) 2004-12-03
MXPA03011317A (es) 2004-03-19
BR0210224A (pt) 2004-04-13
KR20040007665A (ko) 2004-01-24
KR100846945B1 (ko) 2008-07-17
CZ20033340A3 (en) 2004-05-12
US7993673B2 (en) 2011-08-09
CN1538837A (zh) 2004-10-20

Similar Documents

Publication Publication Date Title
IS7946A (is) Lyf
EE200300416A (et) Ravimvorm
DE60210315D1 (de) Tamsulosin tabletten
NO20033556L (no) Farmasöytiske formuleringer
NO20033384L (no) Farmasoytisk formulering
FI20011478A0 (fi) Farmaseuttinen koostumus
NO20040125L (no) Enterale formuleringer
DE60204063D1 (de) Blisterverpackung
NO20023942D0 (no) Tablettmater
NO20035315D0 (no) Farmasöytiske kombinasjoner
NO20035627D0 (no) Farmasöytisk formulering
DK0981334T3 (da) Slugetabletter indeholdende paracetamol
DK1392271T3 (da) Slugetablet indeholdende paracetamol
DE50209245D1 (de) Neuroprotektives medikament
ATE362329T1 (de) Weiche kraftbrühetablette
ATE285753T1 (de) Lysin enthaltende kautablette
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20042502L (no) Farmasoytisk formulering omfattende bicalutamid
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
UA5530S (uk) Таблетка фармацевтична
NO20012601A (no) Slukrist
FI5009U1 (fi) Tabletti
NO20041236L (no) Farmasoytisk formulering
SE0102823D0 (sv) New drug
SE0103116D0 (sv) Pharmaceutical combination